DLTs
DLTs
In cohort Q2W-LD, the DLT-evaluable population comprised 21 of 28 patients, including 3, 3, 6, and 9 patients at LD-DLs 120, 135, 150, and 170 mg/mTwo of 9 DLT-evaluable patients experienced a DLT at the 170 mg/mIn cohort Q3W, all 15 patients were evaluable for DLTs. Two of the 3 DLT-evaluable patients at the 190 mg/mOn the basis of these observations, the MTD was defined as a LD of 170 mg/m